All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Montmorillonite Poly-L-lactide microcomposites of procainamide for controlled drug delivery: In vitro and in vivo evaluation

Author(s): Kevadiya BD1, Patel TK2, Patel PB2, Rajkumar S1, Tripathi CB2, Bajaj HC3
1Institute of Science, Nirma University, S. G. highway, Ahmedabad-382 481, India. 2Department of Pharmacology, Government Medical College, Bhavnagar University, Bhavnagar-364 002, India. 3Research Institute, Council of Scientific and Industrial Research (CSIR), Bhavnagar-364 002, India.

Correspondence Address:
H C Bajaj Discipline of Inorganic Materials and Catalysis, , Council of Scientific and Industrial Research (CSIR), Gijubhai Badheka Marg, Bhavnagar. E-mail: [email protected]


The research work reported in this paper is extension of our previous findings related to intercalation of procainamide hydrochloride, an antiarrythmia drug in interlayer gallery of Na+-clay (montmorillonite). The microcomposite particles prepared from procainamide-montmorillonite hybrid and poly L-lactide were characterised by scanning electron microscope and atomic force microscopy analysis. In vitro drug release study in simulated intestinal fluid showed controlled release pattern up to ~72 h and significant reduction in the drug release in gastric environment. In vivo pharmacokinetics and biodistribution in rats showed that the plasma/tissue drug levels were within therapeutic window as compared with free drug. The data from toxicity biomarker estimations and clinical biochemistry/ haematological parameters showed significant reduction in drug toxicity when formulated in montmorillonite/poly L-lactide as compared with free drug, which is of considerable value in achieving improved therapy with reduced side effects.



Share this